The Biobased and Renewable Products Advocacy Group (BRAG) helps members develop and bring to market their innovative biobased and renewable chemical products through insightful policy and regulatory advocacy. BRAG is managed by B&C® Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C.

By Lauren M. Graham, Ph.D.

On July 11, 2017, DOE announced the selection of three projects focused on reducing the costs of producing algal biofuels and bioproducts that will receive up to $8 million in funding.    The projects aim to generate high-impact tools and techniques for increasing the productivity of algae organisms and cultures and biology-focused breakthroughs.  The project winners include:

  • Lumen Bioscience, which will work with the National Renewable Energy Laboratory on the agricultural production of algae on otherwise non-productive land in rural eastern Washington State by rapidly engineering strains that grow robustly in seawater, resist contamination and predation, and accumulate substantial amounts of energy-rich components;
  • Global Algae Innovations, which will work in partnership with Sandia National Laboratories, University of California at San Diego – Scripps Institution of Oceanography, and the J. Craig Venter Institute to deliver a tool for low cost, rapid analysis of pond microbiota, gather data on the impacts of pond ecology, and develop new cultivation methods that utilize this information to achieve greater algal productivity; and
  • Los Alamos National Laboratory, which will work with Sapphire Energy to help the algal research and development community better understand these metrics at commercial scales by evaluating rationally designed pond cultures containing multiple species of algae, as well as beneficial bacteria, to achieve consistent biomass composition and high productivity.

 

The BIO World Congress on Industrial Biotechnology will take place on July 23-26, 2017, at the Palais des congrès de Montréal.  Bergeson & Campbell, P.C. (B&C®) will co-host a Bioeconomy Leaders and Innovators Reception with Sterne, Kessler, Goldstein & Fox P.L.L.C. from 6:00-7:30 p.m. on July 25, 2017.  Enjoy cocktails and hors d’oeuvres while engaging with colleagues to exchange ideas and explore the prospect of establishing new partnerships.  Christine Lhulier, Corporate Counsel for DuPont Industrial Biosciences, will participate in a brief question and answer (Q&A) session to initiate dialog for the evening.  Register for the reception
 
Richard E. Engler, Ph.D., Senior Chemist with B&C, and Lauren M. Graham, Ph.D., Manager of the Biobased and Renewable Products Advocacy Group (BRAG®), will be attending the conference and will be pleased to discuss questions attendees may have about their own biotechnology products. 

We look forward to seeing you there! 


 

By Lauren M. Graham, Ph.D.

On June 29, 2017, Representatives Bill Pascrell (D-NJ), Ryan Costello (R-PA), Brian Fitzpatrick (R-PA), and Linda Sánchez (D-CA) introduced the Renewable Chemicals Act of 2017 to the House.  If enacted, the legislation would create a targeted, short-term tax credit for the production of qualifying renewable chemicals from biomass and for investments in renewable chemical production facilities.  The tax credit would be provided based on job creation, innovation, environmental benefits, commercial viability, and contribution to U.S. energy independence.  Numerous industry stakeholders, including the Biotechnology Innovation Organization (BIO), Renmatix, and DSM, praised the proposed legislation. 


 

By Lauren M. Graham, Ph.D.

On June 30, 2017, the National Academies of Sciences, Engineering, and Medicine (NAS) released the final version of its report Preparing for Future Products of Biotechnology, which is the result of a collaboration by a committee of experts convened by NAS.  The report provides an overview of the committee’s discussion on “the future products of biotechnology that are likely to appear on the horizon, the challenges that the regulatory agencies might face, and the opportunities for enhancing the regulatory system to be prepared for what might be coming.”  The committee reached consensus on its conclusions and recommendations regarding actions that can be taken to enhance the capabilities of the biotechnology regulatory system to prepare for the anticipated future of biotechnology products, which are also presented in the report.
 
More information on the NAS report is available in the Biobased and Renewable Product Advocacy Group (BRAG®) blog post “NAS Releases Final Report on Preparing for Future Products of Biotechnology.”


 

The BIO World Congress on Industrial Biotechnology takes place July 23-26, 2017, at the Palais des congrès de Montréal.  Bergeson & Campbell, P.C. (B&C®) will co-host a Bioeconomy Leaders and Innovators Reception with Sterne, Kessler, Goldstein & Fox P.L.L.C. from 6:00-7:30 p.m. on July 25, 2017.  Enjoy cocktails and hors d’oeuvres while engaging with colleagues to exchange ideas and explore the prospect of establishing new partnerships.  Christine Lhulier, Corporate Counsel for DuPont Industrial Biosciences, will participate in a brief question and answer (Q&A) session to initiate dialog for the evening. Register for the reception
 
Richard E. Engler, Ph.D., Senior Chemist with B&C, and Lauren M. Graham, Ph.D., Manager of BRAG, will be attending the conference and will be pleased to discuss questions attendees may have about their own biotechnology products. 
 
We look forward to seeing you there!


 

By Lynn L. Bergeson and Margaret R. Graham

On June 30, 3017, the National Academies of Sciences, Engineering, and Medicine (NAS) released its final version of its report Preparing for Future Products of Biotechnology, which it states “analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making [and] … identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.”  This report is a collaboration among a committee of experts including the Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System (Committee), the Board on Life Sciences, the Board on Agriculture and Natural Resources, the Board on Chemical Sciences and Technology, and the Division on Earth and Life Studies and sponsored by the U.S. Environmental Protection Agency (EPA), the U.S. Department of Agriculture (USDA), and the U.S. Food and Drug Administration (FDA).  Lynn L. Bergeson was an external contributor to the Committee’s deliberations and presented before the Committee on the subject of the biotechnology regulatory system.  

The report includes sections on emerging trends and products of biotechnology; the current biotechnology regulatory system; understanding risks related to future biotechnology products; opportunities to enhance the capabilities of the biotechnology regulatory system; and an index on congressionally defined product categories that FDA regulates; as well as conclusions and recommendations that were included in our blog item on the prepublication version.

More information on the regulatory issues of biotechnology products is available on our biobased products blog under key word biotechnology, as well as the Bergeson & Campbell, P.C. (B&C®) regulatory developments website under key phrase biobased products, biotechnology.


 

The BIO World Congress on Industrial Biotechnology takes place July 23-26, 2017, at the Palais des congrès de Montréal, and features two new tracks on Flavors, Fragrances and Food Ingredients, and Agricultural Crop Technologies and Biomass Supply.  Bergeson & Campbell, P.C. (B&C®) will co-host a Bioeconomy Leaders and Innovators Reception on July 25, 2017, with Sterne, Kessler, Goldstein & Fox P.L.L.C.  More details to come.  Richard E. Engler, Ph.D., Senior Chemist with B&C, will be attending the conference and will be pleased to discuss questions attendees may have about their own biotechnology products. 
 
There is still time to register online.  We look forward to seeing you there!


 

By Lauren M. Graham, Ph.D.

On June 7, 2017, the National Corn Growers Association (NCGA), along with innovation facilitator NineSigma, announced the launch of a global competition to identify new and innovative uses for corn as a renewable feedstock for making sustainable chemicals with significant market demand.  The Consider Corn Challenge is intended to be a starting point to help industry realize the full potential of corn by inspiring new concepts, approaches, and technologies that will help drive innovation.  NCGA will select up to six winning proposals from industry, academia, and other research institutions that consider new ways to utilize corn and maximize its contributions to the economy.   Winners will be announced in February 2018 and each will receive $25,000.  Responses to the Consider Corn Challenge are due by 5:00 p.m. (EDT) on September 28, 2017.  More information on the challenge is available at the NineSigma website.


 

By Lauren M. Graham, Ph.D.

On June 14, 2017, the Biotechnology Innovation Organization (BIO) announced that biotech industry veteran Vonnie Estes would receive the 4th annual Rosalind Franklin Award for Leadership in Industrial Biotechnology. Estes, an independent business consultant, will be presented the Rosalind Franklin Award for Leadership in Industrial Biotechnology during a lunch plenary session at the BIO World Congress on July 25, 2017.  Each year, the award celebrates a pioneering woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation in honor of Rosalind Franklin.  Estes was selected as a result of her numerous contributions to the commercial development of new biotechnologies, creating revolutionary products that are good for people and the planet.  Throughout her career, Estes has held leadership positions at DuPont, GranBio, Caribou Biosciences, Monsanto, and Syngenta.  Estes’ role as an accomplished industry leader with decades of experience commercializing industrial biotechnology innovations and developing emerging companies was determined to honor Rosalind Franklin’s legacy.


 

By Lauren M. Graham, Ph.D.

On June 15, 2017, Richard E. Engler, Ph.D., Senior Chemist at Bergeson & Campbell, P.C. (B&C®), presented at Products as Solutions to Real-World Sustainability Challenges: Incentives & Barriers, a session at the 2017 Green Chemistry & Engineering Conference (GC&E).  Dr. Engler’s presentation, “TSCA, its effects on renewable feedstocks, and how TSCA reform has changed things,” provided an overview of the Toxic Substances Control Act (TSCA) and aspects of TSCA reform that impact green chemistry, including both biobased materials and sourcing from byproducts or other wastes.  The presentation discussed how the use of a chemical substance determines TSCA regulatory requirements for the entire supply chain, including starting materials, intermediates, and catalysts (including enzymes and microbes).  To demonstrate this point, Dr. Engler reviewed scenarios under which TSCA reporting requirements for byproduct generators and processors would change based on how the byproduct is processed and used.  Dr. Engler highlighted the need for communication on TSCA reporting throughout the supply chain to ensure compliance and minimize potential commercial disruptions.
 
For more information or to request copies of the presentation materials, please contact .(JavaScript must be enabled to view this email address).


 
 1 2 3 >  Last ›